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Aims
Isolated gonadotropin-releasing hormone (GnRH) defi-
ciency (IGD) is characterized by delayed or absent sex-
ual development associated with low gonadotropin and
sex steroid levels. IGD is classified as Kallmann syn-
drome (KS) with anosmia and normosmic idiopathic
hypogonadotropic hypogonadism (nIHH). This study
was undertaken to investigate clinical and endocrinolo-
gical profiles in patients with KS and nIHH during
childhood and adolescence in Korea.
Methods
Twenty nine patients (24 males and 5 females) were
included. Their clinical, endocrinological, and radiologic
findings were analyzed by retrospective medical record
review. In all patients, all exons and intronic flanking
regions of the GNRH1, GNRHR, KISS1, KISS1R,
PROK2, PROKR2, TAC3, TACR3, FGF8, FGFR1, KAL1,
CHD7, and SOX10 genes were amplified by PCR with
specific primers and directly sequenced.
Results
Of 29 patients, 14 were KS and 15 were nIHH. At diag-
nosis, mean chronologic age was 16.55 ± 3.76 years;
height SDS was -0.92 ± 1.53; testis volume was 2.10 ±
1.25 mL; and Tanner stage was 1.45. There were asso-
ciated anomalies in some KS patients: 6 patients with
hearing loss, 4 patients with congenital heart disease,
and 2 patients with cryptorchidism. Absence or hypopla-
sia of the olfactory bulb or sulci was found in 9 (82.82%)
KS patients. Peak LH and FSH levels were 5.64 ± 5.83
and 5.11 ± 4.61 mIU/mL after GnRH stimulation. Base-
line testosterone levels were 0.46 ± 0.62 ng/mL. Twenty
four patients (20 males, 4 females) received hormone
replacement therapy for 51.1 months of duration. Dur-
ing the follow-up period, all patients reached final adult
height of 173.29 ± 8.07 cm (0.27 ± 1.03 SDS). Of
29 patients from 28 unrelated families, molecular defects
were identified in 6 patients from 5 families (17.9%, 5/28
pedigrees) in KAL1, SOX10, and CHD7. Two male sib-
lings with KS harbored a novel heterozygous mutation
of p.W380* in KAL1. Two unrelated female patients
with typical and partial/incomplete CHARGE syndrome
were heterozygous for frameshift (p.A608Gfs*4) and
nonsense (p.W983*) mutations in CHD7, respectively. A
31-year-old male with KS and deafness harbored a het-
erozygous p.M112I mutation in SOX10.
Conclusion
This study described clinical, endocrinological, and mole-
cular genetic features in relatively large cohort of IGD
patients. Although the mutation screening was performed
in ten genes responsible for causing IGD, molecular
defects were identified in relatively small proportions of
cohort.
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